| Literature DB >> 32034942 |
Jonathan E Schulz1, Stephanie N Seifert1, John T Thompson1, Victoria Avanzato1, Spencer L Sterling2, Lianying Yan2, Michael C Letko1, M Jeremiah Matson1,3, Robert J Fischer1, Alexandre Tremeau-Bravard4, Janine F R Seetahal5, Vernie Ramkissoon5, Jerome Foster5, Tracey Goldstein4, Simon J Anthony6, Jonathan H Epstein7, Eric D Laing2, Christopher C Broder2, Christine V F Carrington5, Tony Schountz8, Vincent J Munster1.
Abstract
Bat-borne zoonotic pathogens belonging to the family Paramxyoviridae, including Nipah and Hendra viruses, and the family Filoviridae, including Ebola and Marburg viruses, can cause severe disease and high mortality rates on spillover into human populations. Surveillance efforts for henipaviruses and filoviruses have been largely restricted to the Old World; however, recent studies suggest a potentially broader distribution for henipaviruses and filoviruses than previously recognized. In the current study, we screened for henipaviruses and filoviruses in New World bats collected across 4 locations in Trinidad near the coast of Venezuela. Bat tissue samples were screened using previously established reverse-transcription polymerase chain reaction assays. Serum were screened using a multiplex immunoassay to detect antibodies reactive with the envelope glycoprotein of viruses in the genus Henipavirus and the family Filoviridae. Serum samples were also screened by means of enzyme-linked immunosorbent assay for antibodies reactive with Nipah G and F glycoproteins. Of 84 serum samples, 28 were reactive with ≥1 henipavirus glycoprotein by ≥1 serological method, and 6 serum samples were reactive against ≥1 filovirus glycoproteins. These data provide evidence of potential circulation of viruses related to the henipaviruses and filoviruses in New World bats. Published by Oxford University Press for the Infectious Diseases Society of America 2020.Entities:
Keywords: Bats; Filovirus; Henipavirus; Luminex; RT-PCR; Screening; Serology; Trinidad
Mesh:
Year: 2020 PMID: 32034942 PMCID: PMC7213578 DOI: 10.1093/infdis/jiz648
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226